跳至主要内容
临床试验/NCT06538831
NCT06538831招募中不适用

A 2x2 Factorial Randomized Controlled Trial to Elucidate How Ultra-processed Foods Modulate Cardiometabolic Risk

Laval University2 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2024年9月25日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
120
试验地点
2
主要终点
Post treatment insulin sensitivity (HOMA-IR)

研究概览

简要总结

The goal of this clinical trial is to examine in a 2x2 factorial RCT what feature(s) of ultra-processed foods (UPFs) contribute to cardiometabolic risk in men and women. The project's hypotheses are :

  1. that the nutrient composition of UPFs (high SFA, free sugar and sodium) per se has deleterious impacts on cardiometabolic risk factors;
  2. that the industrial techniques and processes of UPFs per se do not.

Participants will be randomly assigned to one of 4 groups consistent with the 2x2 factorial design of the study: 1- the nutrient composition of foods (low vs. high in SFA, free sugar and sodium) and 2- the degree of industrial techniques and food processing (little to no vs.important amounts of UPFs). All foods will be provided to participants under isocaloric conditions during the 6-week dietary intervention. Participants will have to consume one of the 4 experimental diets for 6 weeks.

详细描述

This study is a parallel group 2x2 factorial randomized controlled trial, in which diet is fully controlled. A total of 120 men and women covering a broad range of adiposity and cardiometabolic risk factors will be randomly assigned to one of four 6-week experimental diets:

  1. A diet low in saturated fatty acids (SFAs), free sugar and sodium, with low ultra-processed foods (UPFs)
  2. A diet rich in SFAs, free sugar and sodium, with low UPFs;
  3. A diet low in SFAs, free sugar and sodium, with high levels of UPFs;
  4. A diet rich in SFAs, free sugar and sodium, with high levels of UPFs.

All foods in this full-feeding trial will be managed or prepared by food technicians at the Clinical Investigation Unit of our research center. A cyclic seven-day menu plan will be developed with similar foods across the four diets. Classifications of the degree of food processing will be made using NOVA classification. NOVA identifies four categories of foods based on the degree of food processing: 1- Unprocessed or minimally processed foods, 2- Processed Culinary Ingredients, 3- Processed Food and 4- Ultra-processed foods (UPFs). The two diets high in UPFs will predominantly feature commercially-bought foods classified as NOVA-4, while the two diets low in UPFs diets will predominantly include foods prepared in our metabolic kitchen (NOVA 1 to 3). Diets will be provided under isocaloric conditions to maintain body weight constant. The breakfast meal will represent approximately 30% of the daily energy intake in each diet, whereas the lunch and dinner meals each will provide about 35% of daily energy intake. Participants will have to come to the research center 3 to 5 times a week during the 6-week intervention to collect their meals and be weighed. Primary and secondary outcomes will be measured at the beginning and at the end of the 6-wk diet intervention.

The specifics objectives of this 2x2 factorial RCT are:

Obj 1: To assess the impact of the nutrient composition of UPFs on cardiometabolic risk, independent of variations in industrial techniques and processes (factor 1).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Factorial
主要目的
Prevention
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Body mass index (BMI):18 to 35 kg/m2
  • Stable weight over the last 3 months (variation of less than 5 kg)
  • LDL-cholesterol < 5.0 mmol/L
  • HbA1c < 6.5%
  • Office blood pressure <150/90 mmHg
  • Non-smokers or smokers of less than 10 cigarettes a day

排除标准

  • Pregnant or breast-feeding women
  • Alcohol consumption of more than 7 drinks per week
  • Women: contraceptives for less than 3 months or hormone therapy for less than 6 months
  • Medication to treat hypercholesterolemia, diabetes or hypertension
  • Diagnosis of cardiovascular disease, diabetes, hypertension, cancer
  • Food allergies or aversions to any of the foods on the experimental menus
  • Being on a diet or following a special diet
  • Daytime MAPA blood pressure >150/90

结局指标

主要结局

Post treatment insulin sensitivity (HOMA-IR)

时间窗: 6 weeks

Insulin sensitivity (HOMA-IR) will be measured in the fasted state at the end of the 6-wk intervention in all subjects in each group, on two consecutive days post-treatment. The mean of the two post-treatment values will be used in the analyses. Analyses will be adjusted for insulin sensitivity (HOMA-IR) values measured in the fasted state at baseline.

Post treatment fasting LDL-C concentrations

时间窗: 6 weeks

Fasting serum LDL-C concentrations (mmol/L) will be measured at the end of the 6-wk intervention in all subjects in each group, on two consecutive days post-treatment. The mean of the two post-treatment values will be used in the analyses. Analyses will be adjusted for LDL-C concentrations values measured at baseline.

Post treatment day-time ambulatory systolic blood pressure

时间窗: 6 weeks

Day-time ambulatory systolic blood pressure will be measured at the end of the 6-wk intervention in all subjects in each group. Analyses will be adjusted for day-time ambulatory systolic blood pressure values measured at baseline.

次要结局

  • Post treatment fasting triglyceride(6 weeks)
  • Post treatment ApoB-100(6 weeks)
  • Post treatment HDL-C concentrations(6 weeks)
  • Post treatment fasting glucose concentrations(6 weeks)
  • Post treatment fasting insulin concentrations(6 weeks)
  • Post treatment day-time ambulatory diastolic blood pressure(6 weeks)
  • Post treatment 24-hr ambulatory systolic blood pressure(6 weeks)
  • Post treatment 24-hr ambulatory diastolic blood pressure(6 weeks)
  • On-treatment Diet palatability(6 weeks)
  • On-treatment Perceived healthiness of meals(6 weeks)
  • On-treatment Hunger and fullness perceptions(6 weeks)
  • Post-treatment Gut microbiota(6 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Benoit Lamarche

Study director

Laval University

研究点 (2)

Loading locations...

相似试验